|
NOL9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69928000000041E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.97067999999634E-05 |
| Normal-vs-Stage2 |
4.542100E-03 |
| Normal-vs-Stage3 |
7.898700E-03 |
| Normal-vs-Stage4 |
2.10589999999344E-05 |
| Stage1-vs-Stage2 |
8.008600E-01 |
| Stage1-vs-Stage3 |
9.853200E-01 |
| Stage1-vs-Stage4 |
1.007030E-01 |
| Stage2-vs-Stage3 |
8.159000E-01 |
| Stage2-vs-Stage4 |
3.740000E-01 |
| Stage3-vs-Stage4 |
1.998200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.61429999999885E-05 |
| Normal-vs-AfricanAmerican |
2.19409999999698E-05 |
| Normal-vs-Asian |
2.041900E-03 |
| Caucasian-vs-AfricanAmerican |
4.596800E-01 |
| Caucasian-vs-Asian |
5.121400E-01 |
| AfricanAmerican-vs-Asian |
5.775000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48990000004012E-07 |
| Normal-vs-Female |
2.541400E-01 |
| Male-vs-Female |
4.495700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.075000E-03 |
| Normal-vs-Extreme_Weight |
3.7547999998111E-07 |
| Normal-vs-Obese |
1.817400E-03 |
| Normal-vs-Extreme_Obese |
1.504440E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.726600E-01 |
| Normal_Weight-vs-Obese |
7.402000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.039200E-01 |
| Extreme_Weight-vs-Obese |
9.838300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.336200E-01 |
| Obese-vs-Extreme_Obese |
4.371600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.759600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.155900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.10819999965939E-07 |
| Normal-vs-Age(81-100Yrs) |
1.57882999999304E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.047000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.151800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.162300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.754400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.780400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.769200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34340000004885E-06 |
| Normal-VS-Type2 PRCC |
1.84694999999513E-05 |
| Normal-VS-KIRP CIMP |
9.496500E-02 |
| Normal-VS-Unclassified PRCC |
1.561820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.882200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.313400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.530400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.216000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.459900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.463800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.24029999954467E-07 |
| Normal-vs-N1 |
1.258060E-02 |
| Normal-vs-N2 |
4.695400E-03 |
| N0-vs-N1 |
2.448000E-01 |
| N0-vs-N2 |
8.101800E-01 |
| N1-vs-N2 |
5.065000E-01 |
|
|
